IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system

被引:149
作者
Hagihara, K [1 ]
Nishikawa, T [1 ]
Isobe, T [1 ]
Song, J [1 ]
Sugamata, Y [1 ]
Yoshizaki, K [1 ]
机构
[1] Osaka Univ, Sch Hlth & Sport Sci, Dept Med Sci 1, Osaka, Japan
关键词
SAA; AA amyloidosis; real-time quantitative PCR; IL-6; anti-IL-6 receptor antibody; STAT3;
D O I
10.1016/j.bbrc.2003.12.096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum amyloid A (SAA) is known to be a precursor of amyloid A (AA) protein in AA (secondary) amyloidosis and SAA1 to be mainly involved in AA amyloidosis. We established an SAA isoform real-time quantitative RT-PCR assay and found that beta-2 microglobulin is more stable as an internal control than GAPDH and beta-actin for our system. Either IL-6 and IL-1beta or IL-6 and TNFalpha, but not IL-1beta and TNFalpha, induced the synergistic induction of SAA1 and SAA2 genes. Anti-IL-6 receptor monoclonal antibody completely inhibited the synergistic induction of SAA1 and SAA2 during triple stimulation with IL-6, IL-1beta, and TNFalpha, but, IL-1 receptor antagonist or anti-TNFalpha monoclonal antibody was only partially inhibited in HepG2, Hep3B, and PLC/PRF/5 cells. Although the SAA1 promoter has no STAT3 consensus sequence, the JAK2 inhibitor-AG490 reduced SAA1 gene expression to 30%, suggesting the involvement of STAT3. We were able to demonstrate that IL-6 plays a critical role in the synergistic induction of human SAA gene when stimulated with proinflammatory cytokines. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 32 条
[1]   Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver [J].
Alonzi, T ;
Maritano, D ;
Gorgoni, B ;
Rizzuto, G ;
Libert, C ;
Poli, V .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1621-1632
[2]   A NOVEL ALLELIC VARIANT OF SERUM AMYLOID-A, SAA1-GAMMA - GENOMIC EVIDENCE, EVOLUTION, FREQUENCY, AND IMPLICATION AS A RISK FACTOR FOR REACTIVE SYSTEMIC AA-AMYLOIDOSIS [J].
BABA, S ;
MASAGO, SA ;
TAKAHASHI, T ;
KASAMA, T ;
SUGIMURA, H ;
TSUGANE, S ;
TSUTSUI, Y ;
SHIRASAWA, H .
HUMAN MOLECULAR GENETICS, 1995, 4 (06) :1083-1087
[3]  
BETTS JC, 1993, J BIOL CHEM, V268, P25624
[4]  
Bopst M, 1998, EUR J IMMUNOL, V28, P4130, DOI 10.1002/(SICI)1521-4141(199812)28:12<4130::AID-IMMU4130>3.0.CO
[5]  
2-W
[6]   The genetics of the amyloidoses [J].
Buxbaum, JN ;
Tagoe, CE .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :543-569
[7]  
Charles P, 1999, J IMMUNOL, V163, P1521
[8]   Medical progress - The systemic amyloidoses [J].
Falk, RH ;
Comenzo, RL ;
Skinner, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) :898-909
[9]  
Fantuzzi G, 1996, J IMMUNOL, V157, P291
[10]   Role of cytokines in rheumatoid arthritis [J].
Feldmann, M ;
Brennan, FM ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440